Report cover image

Global Prevent Meningitis Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Publisher APO Research, Inc.
Published Aug 16, 2025
Length 191 Pages
SKU # APRC20355491

Description

Summary

According to APO Research, The global Prevent Meningitis Vaccine market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Prevent Meningitis Vaccine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Prevent Meningitis Vaccine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Prevent Meningitis Vaccine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Prevent Meningitis Vaccine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Prevent Meningitis Vaccine include GSK, China National Biotec Group, Zhejiang Tianyuan, Sanofi Pasteur, Novartis, Merck, Tianjin CanSino Biotechnology, Pfizer and Hualan Bio, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Prevent Meningitis Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Prevent Meningitis Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Prevent Meningitis Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Prevent Meningitis Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Prevent Meningitis Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Prevent Meningitis Vaccine sales, projected growth trends, production technology, application and end-user industry.

Prevent Meningitis Vaccine Segment by Company

GSK
China National Biotec Group
Zhejiang Tianyuan
Sanofi Pasteur
Novartis
Merck
Tianjin CanSino Biotechnology
Pfizer
Hualan Bio
Beijing Tiantan Biological
Baxter International
Zhifei
Wyeth Pharmaceuticals, Inc
Walvax
Serum Institute of India
JN International Medical Corporation
CSL Behring
Bio-Med
Prevent Meningitis Vaccine Segment by Type

Meningococcal AC Vaccine
Meningococcal A Vaccine
Meningococcal B Vaccine (MenB)
Meningococcal Conjugate Vaccine (MenaCWY)
Prevent Meningitis Vaccine Segment by Application

Baby
Teenager
Child
Others
Prevent Meningitis Vaccine Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Prevent Meningitis Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Prevent Meningitis Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Prevent Meningitis Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Prevent Meningitis Vaccine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Prevent Meningitis Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Prevent Meningitis Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Prevent Meningitis Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report

Table of Contents

191 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Prevent Meningitis Vaccine Market Size, 2020 VS 2024 VS 2031
1.3 Global Prevent Meningitis Vaccine Market Size Estimates and Forecasts (2020-2031)
1.4 Global Prevent Meningitis Vaccine Sales Estimates and Forecasts (2020-2031)
1.5 Global Prevent Meningitis Vaccine Market Average Price (2020-2031)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 Global Prevent Meningitis Vaccine Market Dynamics
2.1 Prevent Meningitis Vaccine Industry Trends
2.2 Prevent Meningitis Vaccine Industry Drivers
2.3 Prevent Meningitis Vaccine Industry Opportunities and Challenges
2.4 Prevent Meningitis Vaccine Industry Restraints
3 Prevent Meningitis Vaccine Market by Manufacturers
3.1 Global Prevent Meningitis Vaccine Revenue by Manufacturers (2020-2025)
3.2 Global Prevent Meningitis Vaccine Sales by Manufacturers (2020-2025)
3.3 Global Prevent Meningitis Vaccine Average Sales Price by Manufacturers (2020-2025)
3.4 Global Prevent Meningitis Vaccine Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
3.5 Global Prevent Meningitis Vaccine Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Prevent Meningitis Vaccine Manufacturers, Product Type & Application
3.7 Global Prevent Meningitis Vaccine Manufacturers Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Prevent Meningitis Vaccine Market CR5 and HHI
3.8.2 Global Top 5 and 10 Prevent Meningitis Vaccine Players Market Share by Revenue in 2024
3.8.3 2024 Prevent Meningitis Vaccine Tier 1, Tier 2, and Tier 3
4 Prevent Meningitis Vaccine Market by Type
4.1 Prevent Meningitis Vaccine Type Introduction
4.1.1 Meningococcal AC Vaccine
4.1.2 Meningococcal A Vaccine
4.1.3 Meningococcal B Vaccine (MenB)
4.1.4 Meningococcal Conjugate Vaccine (MenaCWY)
4.2 Global Prevent Meningitis Vaccine Sales by Type
4.2.1 Global Prevent Meningitis Vaccine Sales by Type (2020 VS 2024 VS 2031)
4.2.2 Global Prevent Meningitis Vaccine Sales by Type (2020-2031)
4.2.3 Global Prevent Meningitis Vaccine Sales Market Share by Type (2020-2031)
4.3 Global Prevent Meningitis Vaccine Revenue by Type
4.3.1 Global Prevent Meningitis Vaccine Revenue by Type (2020 VS 2024 VS 2031)
4.3.2 Global Prevent Meningitis Vaccine Revenue by Type (2020-2031)
4.3.3 Global Prevent Meningitis Vaccine Revenue Market Share by Type (2020-2031)
5 Prevent Meningitis Vaccine Market by Application
5.1 Prevent Meningitis Vaccine Application Introduction
5.1.1 Baby
5.1.2 Teenager
5.1.3 Child
5.1.4 Others
5.2 Global Prevent Meningitis Vaccine Sales by Application
5.2.1 Global Prevent Meningitis Vaccine Sales by Application (2020 VS 2024 VS 2031)
5.2.2 Global Prevent Meningitis Vaccine Sales by Application (2020-2031)
5.2.3 Global Prevent Meningitis Vaccine Sales Market Share by Application (2020-2031)
5.3 Global Prevent Meningitis Vaccine Revenue by Application
5.3.1 Global Prevent Meningitis Vaccine Revenue by Application (2020 VS 2024 VS 2031)
5.3.2 Global Prevent Meningitis Vaccine Revenue by Application (2020-2031)
5.3.3 Global Prevent Meningitis Vaccine Revenue Market Share by Application (2020-2031)
6 Global Prevent Meningitis Vaccine Sales by Region
6.1 Global Prevent Meningitis Vaccine Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Prevent Meningitis Vaccine Sales by Region (2020-2031)
6.2.1 Global Prevent Meningitis Vaccine Sales by Region (2020-2025)
6.2.2 Global Prevent Meningitis Vaccine Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Prevent Meningitis Vaccine Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.3.2 North America Prevent Meningitis Vaccine Sales by Country (2020-2031)
6.3.3 U.S.
6.3.4 Canada
6.3.5 Mexico
6.4 Europe
6.4.1 Europe Prevent Meningitis Vaccine Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.4.2 Europe Prevent Meningitis Vaccine Sales by Country (2020-2031)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Prevent Meningitis Vaccine Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.5.2 Asia Pacific Prevent Meningitis Vaccine Sales by Country (2020-2031)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 South America, Middle East and Africa
6.6.1 South America, Middle East and Africa Prevent Meningitis Vaccine Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.6.2 South America, Middle East and Africa Prevent Meningitis Vaccine Sales by Country (2020-2031)
6.6.3 Brazil
6.6.4 South Africa
6.6.5 Saudi Arabia
6.6.6 Turkey
6.6.6 Argentina
6.6.6 UAE
6.6.6 Egypt
6.6.6 Chile
7 Global Prevent Meningitis Vaccine Revenue by Region
7.1 Global Prevent Meningitis Vaccine Revenue by Region
7.1.1 Global Prevent Meningitis Vaccine Revenue by Region: 2020 VS 2024 VS 2031
7.1.2 Global Prevent Meningitis Vaccine Revenue by Region (2020-2025)
7.1.3 Global Prevent Meningitis Vaccine Revenue by Region (2026-2031)
7.1.4 Global Prevent Meningitis Vaccine Revenue Market Share by Region (2020-2031)
7.2 North America
7.2.1 North America Prevent Meningitis Vaccine Revenue (2020-2031)
7.2.2 North America Prevent Meningitis Vaccine Revenue Share by Country: 2020 VS 2024 VS 2031
7.3 Europe
7.3.1 Europe Prevent Meningitis Vaccine Revenue (2020-2031)
7.3.2 Europe Prevent Meningitis Vaccine Revenue Share by Country: 2020 VS 2024 VS 2031
7.4 Asia-Pacific
7.4.1 Asia-Pacific Prevent Meningitis Vaccine Revenue (2020-2031)
7.4.2 Asia-Pacific Prevent Meningitis Vaccine Revenue Share by Country: 2020 VS 2024 VS 2031
7.5 South America, Middle East and Africa
7.5.1 South America, Middle East and Africa Prevent Meningitis Vaccine Revenue (2020-2031)
7.5.2 South America, Middle East and Africa Prevent Meningitis Vaccine Revenue Share by Country: 2020 VS 2024 VS 2031
8 Company Profiles
8.1 GSK
8.1.1 GSK Comapny Information
8.1.2 GSK Business Overview
8.1.3 GSK Prevent Meningitis Vaccine Sales, Price, Revenue and Gross Margin (2020-2025)
8.1.4 GSK Prevent Meningitis Vaccine Product Portfolio
8.1.5 GSK Recent Developments
8.2 China National Biotec Group
8.2.1 China National Biotec Group Comapny Information
8.2.2 China National Biotec Group Business Overview
8.2.3 China National Biotec Group Prevent Meningitis Vaccine Sales, Price, Revenue and Gross Margin (2020-2025)
8.2.4 China National Biotec Group Prevent Meningitis Vaccine Product Portfolio
8.2.5 China National Biotec Group Recent Developments
8.3 Zhejiang Tianyuan
8.3.1 Zhejiang Tianyuan Comapny Information
8.3.2 Zhejiang Tianyuan Business Overview
8.3.3 Zhejiang Tianyuan Prevent Meningitis Vaccine Sales, Price, Revenue and Gross Margin (2020-2025)
8.3.4 Zhejiang Tianyuan Prevent Meningitis Vaccine Product Portfolio
8.3.5 Zhejiang Tianyuan Recent Developments
8.4 Sanofi Pasteur
8.4.1 Sanofi Pasteur Comapny Information
8.4.2 Sanofi Pasteur Business Overview
8.4.3 Sanofi Pasteur Prevent Meningitis Vaccine Sales, Price, Revenue and Gross Margin (2020-2025)
8.4.4 Sanofi Pasteur Prevent Meningitis Vaccine Product Portfolio
8.4.5 Sanofi Pasteur Recent Developments
8.5 Novartis
8.5.1 Novartis Comapny Information
8.5.2 Novartis Business Overview
8.5.3 Novartis Prevent Meningitis Vaccine Sales, Price, Revenue and Gross Margin (2020-2025)
8.5.4 Novartis Prevent Meningitis Vaccine Product Portfolio
8.5.5 Novartis Recent Developments
8.6 Merck
8.6.1 Merck Comapny Information
8.6.2 Merck Business Overview
8.6.3 Merck Prevent Meningitis Vaccine Sales, Price, Revenue and Gross Margin (2020-2025)
8.6.4 Merck Prevent Meningitis Vaccine Product Portfolio
8.6.5 Merck Recent Developments
8.7 Tianjin CanSino Biotechnology
8.7.1 Tianjin CanSino Biotechnology Comapny Information
8.7.2 Tianjin CanSino Biotechnology Business Overview
8.7.3 Tianjin CanSino Biotechnology Prevent Meningitis Vaccine Sales, Price, Revenue and Gross Margin (2020-2025)
8.7.4 Tianjin CanSino Biotechnology Prevent Meningitis Vaccine Product Portfolio
8.7.5 Tianjin CanSino Biotechnology Recent Developments
8.8 Pfizer
8.8.1 Pfizer Comapny Information
8.8.2 Pfizer Business Overview
8.8.3 Pfizer Prevent Meningitis Vaccine Sales, Price, Revenue and Gross Margin (2020-2025)
8.8.4 Pfizer Prevent Meningitis Vaccine Product Portfolio
8.8.5 Pfizer Recent Developments
8.9 Hualan Bio
8.9.1 Hualan Bio Comapny Information
8.9.2 Hualan Bio Business Overview
8.9.3 Hualan Bio Prevent Meningitis Vaccine Sales, Price, Revenue and Gross Margin (2020-2025)
8.9.4 Hualan Bio Prevent Meningitis Vaccine Product Portfolio
8.9.5 Hualan Bio Recent Developments
8.10 Beijing Tiantan Biological
8.10.1 Beijing Tiantan Biological Comapny Information
8.10.2 Beijing Tiantan Biological Business Overview
8.10.3 Beijing Tiantan Biological Prevent Meningitis Vaccine Sales, Price, Revenue and Gross Margin (2020-2025)
8.10.4 Beijing Tiantan Biological Prevent Meningitis Vaccine Product Portfolio
8.10.5 Beijing Tiantan Biological Recent Developments
8.11 Baxter International
8.11.1 Baxter International Comapny Information
8.11.2 Baxter International Business Overview
8.11.3 Baxter International Prevent Meningitis Vaccine Sales, Price, Revenue and Gross Margin (2020-2025)
8.11.4 Baxter International Prevent Meningitis Vaccine Product Portfolio
8.11.5 Baxter International Recent Developments
8.12 Zhifei
8.12.1 Zhifei Comapny Information
8.12.2 Zhifei Business Overview
8.12.3 Zhifei Prevent Meningitis Vaccine Sales, Price, Revenue and Gross Margin (2020-2025)
8.12.4 Zhifei Prevent Meningitis Vaccine Product Portfolio
8.12.5 Zhifei Recent Developments
8.13 Wyeth Pharmaceuticals, Inc
8.13.1 Wyeth Pharmaceuticals, Inc Comapny Information
8.13.2 Wyeth Pharmaceuticals, Inc Business Overview
8.13.3 Wyeth Pharmaceuticals, Inc Prevent Meningitis Vaccine Sales, Price, Revenue and Gross Margin (2020-2025)
8.13.4 Wyeth Pharmaceuticals, Inc Prevent Meningitis Vaccine Product Portfolio
8.13.5 Wyeth Pharmaceuticals, Inc Recent Developments
8.14 Walvax
8.14.1 Walvax Comapny Information
8.14.2 Walvax Business Overview
8.14.3 Walvax Prevent Meningitis Vaccine Sales, Price, Revenue and Gross Margin (2020-2025)
8.14.4 Walvax Prevent Meningitis Vaccine Product Portfolio
8.14.5 Walvax Recent Developments
8.15 Serum Institute of India
8.15.1 Serum Institute of India Comapny Information
8.15.2 Serum Institute of India Business Overview
8.15.3 Serum Institute of India Prevent Meningitis Vaccine Sales, Price, Revenue and Gross Margin (2020-2025)
8.15.4 Serum Institute of India Prevent Meningitis Vaccine Product Portfolio
8.15.5 Serum Institute of India Recent Developments
8.16 JN International Medical Corporation
8.16.1 JN International Medical Corporation Comapny Information
8.16.2 JN International Medical Corporation Business Overview
8.16.3 JN International Medical Corporation Prevent Meningitis Vaccine Sales, Price, Revenue and Gross Margin (2020-2025)
8.16.4 JN International Medical Corporation Prevent Meningitis Vaccine Product Portfolio
8.16.5 JN International Medical Corporation Recent Developments
8.17 CSL Behring
8.17.1 CSL Behring Comapny Information
8.17.2 CSL Behring Business Overview
8.17.3 CSL Behring Prevent Meningitis Vaccine Sales, Price, Revenue and Gross Margin (2020-2025)
8.17.4 CSL Behring Prevent Meningitis Vaccine Product Portfolio
8.17.5 CSL Behring Recent Developments
8.18 Bio-Med
8.18.1 Bio-Med Comapny Information
8.18.2 Bio-Med Business Overview
8.18.3 Bio-Med Prevent Meningitis Vaccine Sales, Price, Revenue and Gross Margin (2020-2025)
8.18.4 Bio-Med Prevent Meningitis Vaccine Product Portfolio
8.18.5 Bio-Med Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Prevent Meningitis Vaccine Value Chain Analysis
9.1.1 Prevent Meningitis Vaccine Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Prevent Meningitis Vaccine Production Mode & Process
9.2 Prevent Meningitis Vaccine Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Prevent Meningitis Vaccine Distributors
9.2.3 Prevent Meningitis Vaccine Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.